Background: The recurrent arteriovenous fistula (AVF) intervention in the treatment of hemodialysis induces pain in patients. Lavender oil has analgesic, antimicrobial, and calming effects. This oil is widely used in patients to reduce anxiety and stress associated with pain caused by analgesics. Method: The present study is a randomized controlled and experimental clinical trial in which patients ( n = 90) who underwent hemodialysis with AVFs were randomly divided into three groups. The intensity of pain was measured in all patients at three different stages during the insertion of arterial needles for hemodialysis: (1) The topical application of 100% lavender essential oil, (2) the inhaler application of 100% lavender essential oil, and (3) no intervention. The placebo (water) was applied to groups 1 and 2. Results: Our findings revealed that the mean pre-application pain scores in hemodialysis patients were 57.58 ± 20.28 in the working group, 48.53 ± 20.23 in the control group, 19.49 ± 15.66 in the post-application group, and 45.33 ± 25.52 in the control group ( p < 0.005). The average pain scores after the application of lavender oil were 22.66 ± 15.35 in the inhaler lavender group, 16.33 ± 15.97 in the topical lavender group, and 45.33 ± 25.52 in the control group. Conclusions: After inhaler and topical application of lavender oil, a significant decrease in the severity of pain was recorded for patients at the time of arterial insertion of needles.

No abstract

No abstract

Chronic kidney disease is an important public health problem in our country as well as all over the world, and the mortality rate in dialysis treatment is 10-30% higher than in the general population. According to the Turkish Nephrology Society 2021 Registry data; there are 83,350 patients with end-stage renal disease in total, as of the end of 2020. The quality of life of those diagnosed with end-stage renal disease is lower than that of the general population and individuals with chronic diseases. In addition, chronic diseases cause sadness, anger, depression, helplessness, fear of death, feeling of uselessness, crying spells, social isolation, fear of being dependent, deterioration in body image, inadequacy and deterioration in quality of life. In dialysis patients, both the conditions caused by the treatment and the perception of chronic disease negatively affect their quality of life. This review has been discussed in order to evaluate the quality of life of patients receiving hemodialysis and peritoneal dialysis treatment models of end-stage renal disease.